Patents by Inventor George H. Foulds

George H. Foulds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6655379
    Abstract: The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at an inspiratory flow rate of less than 17 liters per minute. The bioavailability of the active agent was found to increase at these flow rates when compared to inspiratory flow rates of 17 liters per minute or more.
    Type: Grant
    Filed: March 11, 1999
    Date of Patent: December 2, 2003
    Assignee: Nektar Therapeutics
    Inventors: Andrew Clark, George H. Foulds
  • Publication number: 20030183228
    Abstract: The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at an inspiratory flow rate of less than 17 liters per minute. The bioavailability of the active agent was found to increase at these flow rates when compared to inspiratory flow rates of 17 liters per minute or more.
    Type: Application
    Filed: March 11, 1999
    Publication date: October 2, 2003
    Inventors: ANDREW CLARK, GEORGE H. FOULDS
  • Patent number: 5605889
    Abstract: An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages containing the dosage forms.
    Type: Grant
    Filed: April 29, 1994
    Date of Patent: February 25, 1997
    Assignee: Pfizer Inc.
    Inventors: William J. Curatolo, George H. Foulds, Hylar L. Friedman
  • Patent number: RE39149
    Abstract: An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages containing the dosage forms.
    Type: Grant
    Filed: January 20, 2005
    Date of Patent: June 27, 2006
    Assignee: Pfizer Inc.
    Inventors: William J. Curatolo, George H. Foulds, Hylar L. Friedman